bpc 157 vs prp Doctor Explains BPC-157 The Truth About Stem Cell

Collagen and Bone Morphogenetic Proteins (BMPs) : Preliminary research indicates that BPC 157 may influence the activity of collagen fragments associated with bone morphogenetic proteins (BMPs), which are important for the formation and remodeling of tissues such as bone and cartilage

Featured in a smaller, fragmentary form for easier GI tract absorption, it imparts further anti-inflammatory and immunomodulating benefits for a synergistic healing effect [10, 27, 28, 29]

DO NOT FREEZE

Helps with the metabolism of fats and carbohydrates

The complete side effect frequency breakdown from Phase 2 trials: Very Common (20%+ of patients at 12mg dose) Nausea: 28% Typically mild to moderate, peaks weeks 4-8, usually resolves by week 12 Diarrhea: 24% Usually transient (1-3 weeks), rarely severe Constipation: 21% Paradoxically coexists with diarrhea in different patients Common (10-20% of patients) Vomiting: 17% Decreased appetite: 16% (beyond therapeutic effect) Injection site reactions: 14% Fatigue: 13% Dyspepsia (indigestion): 12% Headache: 11% Uncommon (2-10% of patients) Abdominal pain: 8% Dizziness: 7% Gastroesophageal reflux: 6% Hypoglycemia in diabetics on other medications: 5% Increased heart rate (average 2-4 bpm): 4% Hair thinning/loss: 3% (typically temporary) Rare but Serious (Under 2%) Pancreatitis: 0.3% (3 cases out of 1,032 patients, all resolved with discontinuation) Gallbladder events: 1.4% (expected with rapid weight loss regardless of method) Acute kidney injury: 0.7% (all cases associated with severe dehydration) KEY TAKEAWAY: About 30% experience meaningful nausea in the first 4-8 weeks

Remove the cap on the needle